Lysosomal Therapeutics is Drug Discovery in United States that focus on general health business. Founded in 2011. They cover business area such as developer, therapy, patient, severe neurological disease, movement, cognition, general health, research, development, neurodegeneration, lysosomal disorder, neurodegenerative disease, novel drug discovery, physician, Parkinson.
2011
( 13 years old in 2024 )
General Health
-
19 Blackstone Street
Cambridge, MA 02139
United States
Private
developertherapypatientsevere neurological diseasemovementcognitiongeneral healthresearchdevelopmentneurodegenerationlysosomal disorderneurodegenerative diseasenovel drug discoveryphysicianParkinson
* We use standard office opening hours in near Lysosomal Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lysosomal Therapeutics is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Lysosomal Therapeutics business is focusing on General Health.
Lysosomal Therapeutics headquarter office and corporate office address is located in 19 Blackstone Street Cambridge, MA 02139 United States.
Lysosomal Therapeutics was founded in United States.
In 2024, Lysosomal Therapeutics is currently focus on general health sector.
Above is snippet of Google Trends for "general health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lysosomal Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.